These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 14985063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 6. Aldosterone as a mediator in cardiovascular injury.
    Stier CT, Chander PN, Rocha R.
    Cardiol Rev; 2002 Oct; 10(2):97-107. PubMed ID: 11895576
    [Abstract] [Full Text] [Related]

  • 7. Eplerenone: cardiovascular protection.
    Brown NJ.
    Circulation; 2003 May 20; 107(19):2512-8. PubMed ID: 12756192
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M.
    Circulation; 2004 May 11; 109(18):2213-20. PubMed ID: 15123520
    [Abstract] [Full Text] [Related]

  • 11. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 11; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 12. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF.
    Am J Health Syst Pharm; 2004 May 01; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [Abstract] [Full Text] [Related]

  • 13. The clinical implications of aldosterone escape in congestive heart failure.
    Struthers AD.
    Eur J Heart Fail; 2004 Aug 01; 6(5):539-45. PubMed ID: 15301999
    [Abstract] [Full Text] [Related]

  • 14. Aldosterone blockade in cardiovascular disease.
    Struthers AD.
    Heart; 2004 Oct 01; 90(10):1229-34. PubMed ID: 15367532
    [No Abstract] [Full Text] [Related]

  • 15. The role of aldosterone and aldosterone-receptor antagonists in heart failure.
    Khan NU, Movahed A.
    Rev Cardiovasc Med; 2004 Oct 01; 5(2):71-81. PubMed ID: 15184841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D, Krum H.
    Curr Opin Investig Drugs; 2002 Oct 01; 3(10):1468-73. PubMed ID: 12431020
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.